PofoliaPofolia ile paylaşıldı

New England Journal of Medicine· 2017Q1· Klinik çalışma

İnme Sonrası 6 ila 24 Saat Arasında Defisit ve Enfarkt Arasında Uyumsuzluk Olan Hastalarda Trombektomi

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct

Raul G. Nogueira, Ashutosh P. Jadhav, Diogo C Haussen, Alain Bonafé ve diğerleri

Kısa özet

İskemik inmeden 6 ila 24 saat sonra yapılan endovasküler trombektomi, klinik defisit ve enfarkt hacmi arasında uyumsuzluk gösteren hastalarda fonksiyonel sonuçları önemli ölçüde iyileştirmiştir.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Ana noktalar

  • Trombektomi, geç dönem inme hastalarında 90. günde fonksiyonel bağımsızlığı %33 oranında (49% - 13%) artırmıştır.
  • Ortalama engellilik puanı, trombektomi ile utility-weighted modified Rankin ölçeğinde 2.0 puan iyileşmiştir.
  • Faydalar, inme başlangıcından 6-24 saat sonra klinik defisit ve enfarkt arasında uyumsuzluk gösteren hastalarda görülmüştür.
  • Semptomatik hemoraji ve 90 günlük mortalite oranları, trombektomi ve standart bakım grupları arasında benzerdi.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Özet (abstract)

BACKGROUND: The effect of endovascular thrombectomy that is performed more than 6 hours after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is disproportionately severe relative to the infarct volume may benefit from late thrombectomy. METHODS: We enrolled patients with occlusion of the intracranial internal carotid artery or proximal middle cerebral artery who had last been known to be well 6 to 24 hours earlier and who had a mismatch between the severity of the clinical deficit and the infarct volume, with mismatch criteria defined according to age (<80 years or ≥80 years). Patients were randomly assigned to thrombectomy plus standard care (the thrombectomy group) or to standard care alone (the control group). The coprimary end points were the mean score for disability on the utility-weighted modified Rankin scale (which ranges from 0 [death] to 10 [no symptoms or disability]) and the rate of functional independence (a score of 0, 1, or 2 on the modified Rankin scale, which ranges from 0 to 6, with higher scores indicating more severe disability) at 90 days. RESULTS: A total of 206 patients were enrolled; 107 were assigned to the thrombectomy group and 99 to the control group. At 31 months, enrollment in the trial was stopped because of the results of a prespecified interim analysis. The mean score on the utility-weighted modified Rankin scale at 90 days was 5.5 in the thrombectomy group as compared with 3.4 in the control group (adjusted difference [Bayesian analysis], 2.0 points; 95% credible interval, 1.1 to 3.0; posterior probability of superiority, >0.999), and the rate of functional independence at 90 days was 49% in the thrombectomy group as compared with 13% in the control group (adjusted difference, 33 percentage points; 95% credible interval, 24 to 44; posterior probability of superiority, >0.999). The rate of symptomatic intracranial hemorrhage did not differ significantly between the two groups (6% in the thrombectomy group and 3% in the control group, P=0.50), nor did 90-day mortality (19% and 18%, respectively; P=1.00). CONCLUSIONS: Among patients with acute stroke who had last been known to be well 6 to 24 hours earlier and who had a mismatch between clinical deficit and infarct, outcomes for disability at 90 days were better with thrombectomy plus standard care than with standard care alone. (Funded by Stryker Neurovascular; DAWN ClinicalTrials.gov number, NCT02142283 .).

Yazarların özeti; kaynağından alınmıştır. New England Journal of Medicine, 2017 · DOI ↗

ÇıkarımlarPremium
Makaleye SorÜcretsiz hesapla

Ücretsiz hesapla devam et

Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.

Web'de ücretsiz devam et

Google ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.

Telefonda:

Alan: Epidemiyoloji

EpidemiologyMedicine